Pemetrexed Disodium (Alimta) will now be available across the NHS for malignant pleural mesothelioma in certain cases after NICE threw out an appeal.
After a two-and-a-half-year wait because of approval processes NICE has recommended Pemetrexed Disodium for patients who have WHO performance status of 0 (able to carry out all normal activity without restriction) or 1 (restricted in strenuous activity but able to move around and carry out light work), or who are considered to have advanced disease or for whom surgical resection is considered inappropriate.
Mesothelioma is uncurable but the drug can increase life expectancy and reduce symptoms. At present Pemetrexed Disodium is available in certain areas of the country but its prescription is not widespread across the UK.
source:http://www.legal-medical.co.uk/news/11750.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment